263 related articles for article (PubMed ID: 22533401)
1. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
5. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
Chang SC; Chang CC; Chang TJ; Wong ML
J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium.
Espinosa Los de Monteros A; Millán MY; Ordás J; Carrasco L; Reymundo C; Martín Las de Mulas J
Vet Pathol; 2002 Mar; 39(2):247-56. PubMed ID: 12009063
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
[TBL] [Abstract][Full Text] [Related]
12. Mammary gland tumors in male dogs.
Saba CF; Rogers KS; Newman SJ; Mauldin GE; Vail DM
J Vet Intern Med; 2007; 21(5):1056-9. PubMed ID: 17939564
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.
Case A; Brisson BK; Durham AC; Rosen S; Monslow J; Buza E; Salah P; Gillem J; Ruthel G; Veluvolu S; Kristiansen V; Puré E; Brown DC; Sørenmo KU; Volk SW
PLoS One; 2017; 12(7):e0180448. PubMed ID: 28683102
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and their inhibitors in canine mammary tumors.
Aresu L; Giantin M; Morello E; Vascellari M; Castagnaro M; Lopparelli R; Zancanella V; Granato A; Garbisa S; Aricò A; Bradaschia A; Mutinelli F; Dacasto M
BMC Vet Res; 2011 Jul; 7():33. PubMed ID: 21726449
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of CHIP in canine mammary gland tumors.
Wang H; Yang X; Jin Y; Pei S; Zhang D; Ma W; Huang J; Qiu H; Zhang X; Jiang Q; Sun W; Zhang H; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1465-71. PubMed ID: 26156079
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
17. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological prognostic factors in canine mammary tumors.
Pérez Alenza MD; Peña L; Nieto AI; Castaño M
Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
